Skip to main content
SpringerLink
Log in

Psychodysleptica

  • Chapter
Book cover Rauschdrogen

  • 49 Accesses

Zusammenfassung

Vorbemerkung: Die Zusammenfassung psychotroper Substanzen der verschiedensten chemischen Struktur und Anwendungsformen unter Oberbegriffen erfolgt in diesem Buch in erster Linie im Hinblick auf vergleichbare durch sie ausgelöste psychische Wirkungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abel EL (1971) Marihuana and memory: acquisition or retrieval? Science 173:1038–1040

    Article  Google Scholar 

  • Abel EL (1976) The scientific study of marihuana. Hall, Chicago

    Google Scholar 

  • Abelson PH (1968) LSD and marihuana. Science 159:89–97

    Google Scholar 

  • Aberle D (1966) The Peyote religion among the Navaho. Aldine, Chicago

    Google Scholar 

  • Ablon S L, Goodwin F K (1974) High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients. Am J Psychiatry 131:448–453

    Google Scholar 

  • Abood L G, Biel J H (1962) Anticholinerge Psychotomimetica. Int Rev Neurobiol 4:217–273

    Article  Google Scholar 

  • Agurell S et al. (1971) Metabolism of 7-hydroxy-delta-l-(16)-THC and CBN. Acta Pharm Suec 8

    Google Scholar 

  • Agurell S, Gustafson B, Holmstedt B (1973) Quantitation of A1-tetrahydrocannabinol in plasma from cannabis smokers. J Pharm Pharmac 25:554–448

    Article  Google Scholar 

  • Agurell S, Dewey W L, Willette R E (eds) (1984) The cannabinoids: chemical, pharmacologic and therapeutic aspects. Academic Press, New York

    Google Scholar 

  • Akinloye B A, Court WE (1981) The alkaloids of Rauwolfia volksinii. J Ethnopharmacol 4:99–109

    Article  Google Scholar 

  • Alpert R (1969) Psychedelics and sexual behavior. J Sex Res 5:50–54

    Article  Google Scholar 

  • Amendt G (1974) Haschisch und Sexualität. Enke, Stuttgart

    Google Scholar 

  • Anderson EF (1969) The biogeography, ecology, and taxonomy of lophophora (cactacea). Brittonia 21/4:229–310

    Article  Google Scholar 

  • Andersson PG (1975) Ergotamine headache. Headache 15:118–121

    Article  Google Scholar 

  • Andréasson S, Engström A, Allebeck P, Rydberg U (1988) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 11:1483–1486

    Google Scholar 

  • Andrews G, Vinkenoog S (eds) (1968) The book of grass. Grove, New York

    Google Scholar 

  • Angst J (1970) Halluzinogen-Abusus. Schweiz Med Wochenschr 100:710–715

    Google Scholar 

  • Angst J, Dittrich A, Woggon B (1972) Psychologische und klinische Aspekte des Cannabis-mißbrauchs. Z Allgemeinmed 48:94–99

    Google Scholar 

  • Bachmann EW, Hoffmann A A, Waser P G (1979) Identification of Δ9-tetrahydrocannabinol in human plasma by gas chromatography. J Chrom 178:320–323

    Article  Google Scholar 

  • Baker A A, Lukas EG (1969) Some hospital admissions associated with cannabis. Lancet 1:148–160

    Article  Google Scholar 

  • Barnes C, Fried PA (1974) Tolerance to delta-9-THC in adult rats with differential delta-9-THC exposure with immature or during early adulthood. Psychopharmacology (Berlin) 34:181–190

    Article  Google Scholar 

  • Battegay R, Bäumler J, Gnirss F, Ladewig D (1969) Zur Drogenabhängigkeit vom Typ Cannabis (Haschisch, Marihuana). Schweiz Med Wochenschr 99:965–971

    Google Scholar 

  • Battersby A R (1963) Recent reasearches on indole alkaloids. Pure Appl Chem 6:471–488

    Article  Google Scholar 

  • Bauer W (Hrsg) (1980) Fliegenpilz — Fleisch der Götter, Schamanistische Ekstasekulte in Europa. Trikont, München

    Google Scholar 

  • Baumgartner A M, Jones PF Black CT (.1981) Detection of phencyclidine in hair. J Forensic Sci 26:576–581

    Google Scholar 

  • Baumgartner W A (1986) Analysis of tetrahydrocannabinol (THC) in hair. US Navy Rehabilitation Center Study, Final Report, pp 1–16

    Google Scholar 

  • Beaubrun M H, Knight F (1973) Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. Am J Psychiatry 130:309–311

    Google Scholar 

  • Behr H-G (oJ) Haschisch-Kochbuch. Volksverlag,Linden

    Google Scholar 

  • Behr H-G (1982) Von Hanf ist die Rede. Sphinx, Basel

    Google Scholar 

  • Benitez F (1968) En la tierra màgica del peyote. Biblioteca Era, Serie Popular Mexico

    Google Scholar 

  • Berhardson G, Gunne LM (1972) 46 cases of psychoses in cannabis abusers. Int J Addict 7:9–16

    Google Scholar 

  • Beringer K (1927) Der Meskalinrausch. Springer, Berlin (Neudruck 1969)

    Google Scholar 

  • Beringer K (1932) Zur Klinik des Haschischrausches. Nervenarzt 5:30–41

    Google Scholar 

  • Bialos D S (1970) Adverse marijuana reactions: A critical examination of the literature with selected cas material. Am J Psychiatry 127:819–823

    Google Scholar 

  • Binder MA (1981) Haschisch und Marihuana — was der Arzt über Cannabinoide wissen sollte. Dtsch Ärztebl 78:117–120

    Google Scholar 

  • Bischoff W H (1966) The exstasy drugs. Univ Circle Press, Delray Beach

    Google Scholar 

  • Blaine JD, Meacham M P, Janowsky D S, Schoor M, Bozetti LP (1976) Pharmacology of marijuana. Raven, New York

    Google Scholar 

  • Blevins D, Regan JD (1976) Delta-9-THC. Effect on macromolecular synthesis in human and other mammalian cells. In: Nahas GG, Paton WOM, Idänpää-Heikkilä J F (eds) Marihuana: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 32–68

    Google Scholar 

  • Boettcher C (1866) Über die Anwendung des indischen Hanfes in der Psychiatrie. Berl Klin Wochenschr 3

    Google Scholar 

  • Bonnie R J, Whitebread C H (1978) The marihuana conviction. Univ Press of Virginia, Charlottesville

    Google Scholar 

  • Bogusz M, Schmidt G (1990) Forensisch-toxikologische Aspekte des Cannabis-Mißbrauchs. Zbl Rechtsmed 33:383–398

    Google Scholar 

  • Borg J, Gershon S, Alpert M (1975) Dose effects of smoked marihuana on human cognitive and motor function. Psychopharmacologia 42:211–218

    Article  Google Scholar 

  • Boroffca A (1978) Cannabis und Psychiatric Suchtgefahren 24:28–37

    Google Scholar 

  • Bost R O(1988) 3,4-Methylendioxymethamphetamine (MDMA) and other Amphetamine Derivats. J For Sci 33/2:576–587

    Google Scholar 

  • Bové F J (1970) The story of Ergot. Karger, Basel

    Google Scholar 

  • Bowman M, Pihl R (1973) Cannabis: Psychiological effects of chronic heavy use. Psycho-pharmacology (Berlin) 29:159–170

    Article  Google Scholar 

  • Bram S, Bracet P (1976) Inhibition of proliferation and differentation of D. discoideum amoebae by THC and cannabinol. In: Nahas G G, Paton WOM, Idänpää-Heikkilä J F (eds) Marihuana: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 116–138

    Google Scholar 

  • Bratzke H, Klug E (1985) Gewaltdelikte und LSD-Rausch. Beitr gerichtl Med 43:179–186

    Google Scholar 

  • Braude M C, Szara S (eds) (1976) Pharmacology of marijuana. Raven, New York

    Google Scholar 

  • Brawley P et al. (1972) Pharmacology of hallucinogens. Pharmacol Rev 24

    Google Scholar 

  • Bremkamp S (1980) PCP: Learning to like a dangerous drug. J Psychedelic Drugs 12/2:171–172

    Article  Google Scholar 

  • Brickenstein R (1971) Gefahren der Cannabisdrogen für Heranwachsende. Z Allgemeinmed 47:846–851

    Google Scholar 

  • Bromberg W (1934) Marihuana intoxication. Am J Psychiatry 91:303–340

    Google Scholar 

  • Bron B (1979) Psychopathologisches Erscheinungsbild und klinische Bedeutung des Horror-Trips. Suchtgefahren 25/4:167–176

    Google Scholar 

  • Bron B (1987) Drogeninduzierte Intoxikationen und Psychosen. Fortschr Med 5:94–96

    Google Scholar 

  • Brown F C (1972) Halluzinogenic drugs. Thomas, Springfield/IL

    Google Scholar 

  • Brunner T F (1977) Marijuana in Ancient Greece and Rome? J Psychedelic Drugs 9/3:221–225

    Article  Google Scholar 

  • Bschor F (1950) Marihuana. Kriminalistik 4:19–24

    Google Scholar 

  • Bull J (1971) Cerebral atrophy in young Cannabis smokers. Lancet 11:1420–1448

    Article  Google Scholar 

  • Bundeszentrale für gesundheitliche Aufklärung (1995) „Ecstasy“. Köln

    Google Scholar 

  • Burroughs W, Ginsberg A (1964) Auf der Suche nach Yagé. Limes, Wiesbaden

    Google Scholar 

  • Burstein S, Kupfer D (1971) Hydroxylation of trans-delta-1-THC by hepatic microsomal oxygenase. Ann. NY Acad Sci 191:32–37

    Article  Google Scholar 

  • Butler J L, Gaines L S, Lenox J R (1976) Effects of marijuana expectation and suggestibility on cognitive functioning. Percept Mot Skills 42:1059–1065

    Article  Google Scholar 

  • Bye R A Jr (1979) Hallucinogenic plants of the tarahumara. J Ethnopharmacol 1:23–48

    Article  Google Scholar 

  • Caldwelle D F et al. (1969) Auditory and visuel threshold effects of marihuana in man. Percept Motor Skills 29:755–759

    Article  Google Scholar 

  • Campbell A M G, Evans M, Thomson J L G, Williams M J (1971) Cerebral atrophy in young cannabis smokers. Lancet:II 1219–1224

    Article  Google Scholar 

  • Campbell A M G, Evans M, Thomson J L G, Williams M J (1972) Cerebral atrophy in young cannabis smokers. Lancet 1:202ff.

    Article  Google Scholar 

  • Carlin A S, Post R D (1971) Patterns of Drug Use Among Marihuana Smokers, J Amer med Ass 218:867–868

    Article  Google Scholar 

  • Carlin A S, Trupin E W (1977) The effect of long-term chronic marijuana use on neuropsychological functioning. Int J Addict 12:36–48

    Google Scholar 

  • Carlin A S et al. (1972) Social facilitation of marihuana intoxication. J Abnorm Psychol 80:132–140

    Article  Google Scholar 

  • Carlson K A (1979) PCP from the other side. J Psychedelic Drugs 11/3:231–238

    Article  Google Scholar 

  • Cashman J (1968) LSD, die Wunderdroge. Ullstein, Frankfurt am Main

    Google Scholar 

  • Casswell M (1975) Cannabis and temporal desintegration on experienced and naive subjects. Science 179:803–805

    Article  Google Scholar 

  • Casto D (1970) Marijuana and the assassins, an etymological investigation. Br J Addict 65:219–225

    Article  Google Scholar 

  • Chait L D, Fischman M W, Schuster C R (1985) „Hangover“ effects the morning after marijuana smoking. Drug Alcohol Depend 15:229–238

    Article  Google Scholar 

  • Chatterjee A (1953) Rauwolfia alkaloids. Fortschr Chem Organ Naturst 10:390–394

    Google Scholar 

  • Cherniak L (1979) The great books of hashish. And/Or Press, Berkeley

    Google Scholar 

  • Chiang C-W, Barnett G (1984) Marijuana effect and delta-9-tetra-hydrocannabinol plasma level. Clin Pharmacol Ther 36:234–238

    Article  Google Scholar 

  • Childers S R et al. (1994) Effects of Amandamide on Cannabinoid Receptors in Rat Brain Membrane. Biochem Parmacol 47:711–714

    Article  Google Scholar 

  • Chopra G S (1973) Studies on psycho-clinical aspects of long-term marihuana use in 124 cases. Int J Addict 8:1015–1026

    Google Scholar 

  • Clark L D, Nakashima E N (1968) Expcrimental studies of marihuana. Am J Psychiatry 125:379–384

    Google Scholar 

  • Claussen U, Korte F (1966) Herkunft, Wirkung und Synthese der Inhaltsstoffe des Haschisch. Naturwissenschaften 21:541–546

    Article  Google Scholar 

  • Co B T, Goodwin D W, Gado M, Mikhael M, Hill S Y (1977) Absence of cerebral atrophy in chronic cannabis users. JAMA 237/12:1229–1230

    Article  Google Scholar 

  • Cohen S (1965) The beyond within — The LSD story. Atheneum, New York

    Google Scholar 

  • Cohen S (1966) A classification of LSD complications. Psychosomatics 7:182–186

    Google Scholar 

  • Cohen S (1967) Psychotomimetics agents. Ann Rev Pharm 7:301–318

    Article  Google Scholar 

  • Cohen S (1982) Cannabis and sex: Multifacted paradoxes. J Psychedelic Drugs:14/1–255–58

    Google Scholar 

  • Colbach E (1971) Marijuana use by GI’s in Vietnam. Am J Psychiatry 128:204–207

    Google Scholar 

  • Coleman J H, Tacker H L, Evans W E, Lemmi H, Britton EL (1976) Neurological manifestations of chronic marihuana intoxication, Part 1 : Paresis of the fourth cranial nerve. Dis Nerv Syst 37:29–38

    Google Scholar 

  • O’Connor JE, Rejent TA (1981) EMIT cannabinoid assay: confirmation by RIA and GC/MS, J Anal Tox 6:168–173

    Article  Google Scholar 

  • Consroe PF, Man D P (1973) Effects of Δ8- and Δ9-tetrahydrocannabinol on experimental induced seizures. Life Sci 13:429–439

    Article  Google Scholar 

  • Cooper R (1978) A guide to British psilocybin mushrooms. Hassle Free Press

    Google Scholar 

  • Crawford W J, Merritt J C (1979) Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Int J Clin Pharmacol Biopharm 17:191–196

    Google Scholar 

  • DalCason T A (1989) The characterization of some 3,4-methylenedioxyphenylisopropyl-amine (MDA) analogs. J For Sci 34/4:928–961

    Google Scholar 

  • Daldrup T, Reudenbach G, Kimm K (1987) Cannabis und Alkohol im Straßenverkehr. Blutalkohol 24:144–155

    Google Scholar 

  • Dalterio S, Bartke A (1979) Perinatal exposure to cannabinoids alters male reproductive function in mice. Science 205:1420–1422

    Article  Google Scholar 

  • Darley C F, Tinklenberg J R, Hollister T E et al. (1973) Marihuana and retrieval from short term memory. Psychopharmacol (Berlin) 29:231–238

    Article  Google Scholar 

  • Daunderer M (1979) Therapie einer Atropa-belladonna-Vergiftung mit dem Antidot Phy-sostigmin. Med Welt 30:1743

    Google Scholar 

  • Davenport J (1966) Aphrodisiacs and love stimulants. Lyle Stuart, New York

    Google Scholar 

  • Devane W A et al. (1992) Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor. Science 258:1946–1947

    Article  Google Scholar 

  • Diaz J L (1979) Ethnopharmacology and taxonomy of Mexican psychodysleptic plants. J Psychedelic Drugs: 11/1–271–101

    Article  Google Scholar 

  • Dieckhöfer K, Goenchea S(1972) Zur Toxizität von Cannabis. 1. Mitteilung. Med Welt 23:779–782

    Google Scholar 

  • Dittrich A, Hofmann A, Leuner M (Hrsg) (1994) Welten des Bewußtseins. Wissenschaft und Bildung, Berlin

    Google Scholar 

  • Domino E F (1981) Cannabinoids and the cholinergic system. J Clin Pharmacol [Suppl] 21:149S-255S

    Article  Google Scholar 

  • Don Castro I I I (1970) Marihuana and the assassins. Br J Addict 65:35–39

    Article  Google Scholar 

  • Doorenbos N J et al. (1971) Cultivation, extraction and analysis of cannabis. Ann NY Acad Sci 191:90–95

    Article  Google Scholar 

  • Dornbush R L, Abrams R, Fink M (1971) Marijuana, memory and perception. Am J Psychiatrie 128:194–197

    Google Scholar 

  • Dowling G P, McDonough E T, Bost R O (1987) „Eve“ and „Ecstasy“. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257/12:1615–1617

    Article  Google Scholar 

  • Eberle P (1973) Verursachen Halluzinogene Chromosomendefekte und Mißbildungen? Nervenarzt 44:281 – 284

    Google Scholar 

  • Edery H, Soroko D, Kunberg W (1971) Structural requirements for cannabinoid activity. Ann NY Sci 191:139–145

    Article  Google Scholar 

  • Efron D H (1970) Psychotomimetic drugs. Raven, New York

    Google Scholar 

  • Efron D, Holmstedt B, Kline N S (eds) (1967) Ethnopharmacological search for psychoactive drugs. Public Health Serv Publ 1645:211–216

    Google Scholar 

  • Eliade M (1956) Schamanismus und archaische Ekstasetechnik. Rascher, Zürich Stuttgart

    Google Scholar 

  • Ellis GM Jr et al. (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Therap 38:572–578

    Article  Google Scholar 

  • Estrada A(1980) Maria Sabina, Botin der heiligen Pilze. Trikont, München

    Google Scholar 

  • Eugster CH (1968) Wirkstoffe aus dem Fliegenpilz. Naturwissenschaften 55:305–313

    Article  Google Scholar 

  • Farnsworth NR (1968) Halluzinogenic plants. Science 162:96–105

    Article  Google Scholar 

  • Feldman H W et al. (eds) (1979) Angel dust: An ethnographic study of PCP users. Lexington Books, Lexington/MA

    Google Scholar 

  • Feuerlein W (Hrsg) (1980) Cannabis heute, Bestandsaufnahme zum Haschischproblem. Akademische Verlagsgesellschaft, Wiesbaden

    Google Scholar 

  • Fink DJ, Ashworth B, Brewer C (1972) Cerebral atrophy in young cannabis smokers. Lancet 1:143–147

    Article  Google Scholar 

  • Fischer C, Hatzidimitrion G, Wios J, Katz J, Recaurte G (1995) Reorganization of Ascending 5-HT Axon Projections in Animals Previously Exposed to the Recreational Drug MDMA (JEcstasy’). Journ. of Neuroscience 8:5476–5485

    Google Scholar 

  • Fisher G, Steckler A (1974) Psychological effects, personality and behavioral changes attributed to marihuana use. Int J Addict 9:101–126

    Google Scholar 

  • Fischer J, Täschner K-L (1991) Flash back nach Cannabis-Konsum — eine Übersicht. Fort-schr Neurol Psychiatr 59

    Google Scholar 

  • Fligiel S E G, Venkat H, Gong H, Tashkin D P (1988) Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study. J Psychoactive Drugs 20:33–42

    Article  Google Scholar 

  • Forstenhäusler D (1993) Synthetische Drogen. Kriminalistik 8–9:533–558

    Google Scholar 

  • Frank M, Rosenthal E (1974) Marijuana Grower’s Guide. And/Or Press, San Francisco

    Google Scholar 

  • Franks H M, Starmer G A, Chesher G B, Jackson D M, Hensley V R, Hensley W J (1975) The interaction of alcohol and delta-9-tetrahydrocannabinol in man. Effects on psychomotor skills related to driving. Add. Res. Fornd. of Ontario, Toronto

    Google Scholar 

  • Frederick D L et al. (1985) Comparison of six cannabinoid metabolite assays. J Anal Toxicol 9:116–120

    Article  Google Scholar 

  • Frederking W (1955) LSD-25 and mescaline in psychotherapy. J Ment Dis 121:70–77

    Google Scholar 

  • Freedman D X (1963) Psychotomimetic drugs and brain biogenic amines. Am J Psychiatry 119:843–850

    Google Scholar 

  • Fried P A (1977) Behavioral and electroencephalographic correlates of the chronic use of marihuana — a review. Bull Narc 29/2:29–34

    Google Scholar 

  • Friedberg C (1965) Des Banisteriopsis utilisés comme drogue en Amérique du sud. J Agric Trop Bot Appl,12:403–437,550–594 729–780

    Google Scholar 

  • Furst PT (1971) Ariocarpus retusus, the „false peyote“ of Huichol tradition. Econ Bot 25/1:182–187

    Article  Google Scholar 

  • Furst P T (ed) (1972) Flesh of the gods: The ritual uses of hallucinogens. Prager, New York

    Google Scholar 

  • Furst P T (1976) Hallucinogens and culture. Chandler & Sharp, San Francisco

    Google Scholar 

  • Galanter M, Wyatt R, Lemberger L et al. (1972) Marijuana intoxication: Interaction between physiologic effects and subjective experience. Science 176:934–936

    Article  Google Scholar 

  • Gale E N, Guenther G (1971) Motivational factors associated with the use of cannabis. Br J Addict 13:30–36

    Google Scholar 

  • Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Sci 86:136–147

    Google Scholar 

  • Garrett E R, Hunt CA (1977) Separation and analysis of A1-tetrahydrocannabinol in biological fluids by high-pressure liqiud chromatography and GLC. J Pharm Sci 66:20–26

    Article  Google Scholar 

  • Gautier T (1846) Le club des hachichins. Revue des Deux Mondes

    Google Scholar 

  • Gerlach D, Schilling S (1984) Phencyclidin, Hinweise zur Erkennung und Behandlung von PCP-Intoxikationen. Suchtgefahren 30:273–279

    Google Scholar 

  • Gielsdorf W, Klug E (1981) Neues Rauschmittel auf dem Drogenmarkt: 2,5-Dimethoxy-4-bromamphetamin (DOB). Dtsch Apoth Z 20:1003–1005

    Google Scholar 

  • Gilmour DG, Bloom AD, Kusum PL, Robbins ES, Maximilian C (1971) Chromosomal aberrations in users of psychoactive drugs. Arch Gen Psychiatry 24:268–272

    Article  Google Scholar 

  • Goenchea S, Dieckhöfer K (1972) Zur Toxizität von Cannabis, 2. Mitteilung. Med Welt 23:1148–1151

    Google Scholar 

  • Goode E (1970) The marijuana smokers. Basic, New York

    Google Scholar 

  • Gorman M, Neuss N, Cone N J (1965) Vinca alkalois, XVII. Chemistry of catharanthine. J Am Chem Soc 87:93

    Article  Google Scholar 

  • Gostomzyk J G, Parade P, Gewecke H (1973) Rauschmittelgenuß und Leistungsfähigkeit (Untersuchungen zur Energiebildung unter Haschisch). Z Rechtsmed 73:131–136

    Article  Google Scholar 

  • Green G S (1984) Discussion of the use of marihuana, ethanol, and other drugs among drivers killed in single vehicle crashes. J Forensic Sci 29:16–21

    Google Scholar 

  • Grinker R R (1964) Bootlegged ecstasy. JAMA 187:768

    Article  Google Scholar 

  • Grinspoon L, Bakalar J B (1981) Psychedelic drugs reconsidered. Basic, New York

    Google Scholar 

  • Grof S (1983) LSD-Psychotherapie. Klett-Cotta, Stuttgart

    Google Scholar 

  • Gröger D (1966) Fortschritte der Chemie und Biochemie der Mutterkornalkaloide. Fortschr Chem Forsch 6:159–164

    Article  Google Scholar 

  • Gross D (1971) Vorkommen, Struktur und Biosynthese natürlicher Piperidinverbindungen. Fortschr Chem Org Naturstoffe 29:1–18

    Google Scholar 

  • Gruenwaldt G (1971) Haschisch, Marihuana, LSD — Eigenschaften, Bedeutung Gefahren. Saarl Ärztebl 24:33–37

    Google Scholar 

  • Grupp SE (1972) Multiple drug use in a sample of experienced smokers. Int J Addict 7:481–491

    Google Scholar 

  • Haan J, Binder M (1980) Psychotrope Drogen: Halluzinogene und Psychostimulatien, Intern Welt 5:153–160

    Google Scholar 

  • Haenel T A (1970) Kulturgeschichte und heutige Problematik des Haschischs. Pharmako-psychiat Neuropsychopharmakol 3:89–115

    Google Scholar 

  • Hai H (1984) Das Hanfhandbuch. Piper, Löhrbach (Der grüne Zweig, Bd 73)

    Google Scholar 

  • Halikas J A, Goodwin D W, Guze S B (1972) Marihuana use and psychiatrie illness. Arch Gen Psychiatry 27:162–165

    Article  Google Scholar 

  • Hallucinogenic and Psychedelic Drug Synthesis. Manual (1976) Salt and Pepper Syndicate. Lawrence/KS

    Google Scholar 

  • Harding R, Knight F (1973) Marihuana-modified mania. Arch Gen Psychiatry 29:635–637

    Article  Google Scholar 

  • Harner M J (ed) (1973) Hallucinogens and shamanism. Oxford Univ Press, London

    Google Scholar 

  • Harvey D J (1985) Marihuana 1984. IRL Press, Oxford

    Google Scholar 

  • Harzer K (1982) Nachweis von LSD in Körperflüssigkeiten mit Hochleistungsflüssigkeits-chromatographie. J Chromatogr 249:205–211

    Article  Google Scholar 

  • Hasse H E, Waldmann H (1971) „Flashback“: Spontane psychotische Episoden als Folgeerscheinung des Phantasticagebrauchs Jugendlicher. Arch Psychiatr Nervenkr 214:399–439

    Article  Google Scholar 

  • Hawkes J G et al. (ed) (1979) The biology and taxonomy of the solanaceae. Academic Press, London

    Google Scholar 

  • Heath R G (1976) Marihuana and delta 9 tetrahydrocannabinol: Acute and chronic effects on brain function of monkeys. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven, New York, pp 345–356

    Google Scholar 

  • Heath R G, Fitzjarrell A T, Garey RE, Myers W A (1979) Chronic marihuana smoking: Its effects on function and structure of the primate brain. In: Nahas G G, Paton WDM (eds) Marihuana: Biological effects. Pergamon, New York, pp 713–730

    Google Scholar 

  • Heim M E (1982) Cannabis und Cannabinoide. Fortschr Med 9:343–346

    Google Scholar 

  • Heim R (1967) Nouvelles investigations sur les champignons hallucinogenes. Editions des Musees Nationaux Histoire Paris

    Google Scholar 

  • Heim R, Wasson R G (1958) Les champignons hallucinogénes du Mexique. Editions des Musees Nationaux Histoire, Paris

    Google Scholar 

  • Heinemann C (1971) Klinisch beobachtete Folgeerscheinungen nach Haschischkonsum. Med Klin (Munich) 66:1648–1653

    Google Scholar 

  • Heinemann C (1973) Nachlassende Wirkung initialer Rauscherlebnisse und Dosissteigerung beim Haschischkonsumenten. Med Klin 68:826–830

    Google Scholar 

  • Helmer R, Wunder R, Zellmann K, Haesen D (1972) Experimentelle Untersuchungen zur Fahrtüchtigkeit nach Einnahme von Haschisch. Blutalkohol 4:213–220

    Google Scholar 

  • Henderson G L (1988) Designer drugs, past history and future prospects. J For Sci 33/2:569–575

    Google Scholar 

  • Henderson R L, Tennant F S, Guerry R (1972) Respiratory manifestations of hashish smoking. Arch Otolaryngol 95:248–251

    Article  Google Scholar 

  • Hepler R S, Frank I M (1971) Marihuana smoking and intraocular pressure. JAMA 217:1392

    Article  Google Scholar 

  • Herer J (1093) Die Wiederentdeckung der Nutzpflanze Hanf-Cannabis-Marihuana. 2000, Frankfurt am Main

    Google Scholar 

  • Herha J (1974) Haschisch und Marihuana — eine Übersicht. Naturwissenschaften 61:90–94

    Article  Google Scholar 

  • Herning RI, Jones R T, Peltzman D J (1979) Changes in human event relate potentials with prolonged delta-9-tetrahydrocannabinol(THC) use. ElectroencephalogrClin Neurophy-siol 47:556–570

    Article  Google Scholar 

  • Hesse M (1964/1968) Indolalkaloide in Tabellen. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Hesse M (1974) Progress in mass spectrometry, vol 1 : Indolalkaloide. Verlag Chemie, Weinheim

    Google Scholar 

  • Hingson R, Alpert J S, Day N et al. (1982) Effects of maternal drinking and marihuana use on fetal growth and development. Pediatrics 70:539–546

    Google Scholar 

  • Hirschfeld G (1995) Techno-Szene und Drogen. Kriminalistik 4:253–256

    Google Scholar 

  • Hirschhorn K, Cohen MM (1968) Drug-induced chromosomal aberrations. Ann NY Acad Sci 151:977–987

    Google Scholar 

  • Hochman J S, Brill N Q (1973) Chronic marijuana use and psychosocial adaption. Am J Psychiatr, 130:132–139

    Google Scholar 

  • Hoffer A, Osmond H (1967) The hallucinogens. Academic Press, New York

    Google Scholar 

  • Hoffman D, Brunnemann K D, Gori G B, Wynder E L (1975) On the carcinogenicity of marihuana smoke. Res Adv Phytochem 9:63–81

    Article  Google Scholar 

  • Hofmann A (1954) Die Isolierung weiterer Alkaloide aus Rauwolfia serpentina Benth. Helv Chim Acta 37:849–865

    Article  Google Scholar 

  • Hofmann A (1960 a) Psychotomimetica, eine Übersicht. Svensk Kem Tidskr 72:79–88

    Google Scholar 

  • Hofmann A (1960 b) Die psychotropen Wirkstoffe der mexikanischen Zauberpilze. Chimia 14:309–318

    Google Scholar 

  • Hofmann A (1961) Die Wirkstoffe der mexikanischen Zauberdroge Ololiuqui. Planta Med 9:354–367

    Article  Google Scholar 

  • Hofman A (1964) Die Mutterkornalkaloide. Enke, Stuttgart

    Google Scholar 

  • Hofmann A (1967) Psychoaktive Stoffe der Pflanzen. Therapiewoche 35:40–47

    Google Scholar 

  • Hofmann A (1979) LSD — mein Sorgenkind. Klett-Cotta, Stuttgart

    Google Scholar 

  • Hofmann A (1981) LSD ist eine sakrale Droge (Interview mit Dr. Hofmann). Psychol Heute 4:55–61

    Google Scholar 

  • Hofmann A, Tscherter H (1960) Isolierung von Lysergsäurealkaloiden aus der mexikanischen Zauberdroge Ololiuqui. Experimentia XVI/9

    Google Scholar 

  • Hokkanen E, Waltimo O, Kallauranta J (1978) Toxic effects of ergotamine used for migraine. Headache 18:95–98

    Article  Google Scholar 

  • Hole G (1967) LSD und verwandte Halluzinogene. Geschichte — Wirkung — Gebrauch und . Gefahren. MMW 109:1389–1397

    Google Scholar 

  • Hollister LE (1968) Chemical psychoses. LSD and related drugs. Thomas, Springfield/IL

    Google Scholar 

  • Hollister L E (1986) Health Aspects of Cannabis. Pharmacol Rev 38:1–20

    Google Scholar 

  • Hollister L E, Gillespie H K, Ohlsson A (1981) Do plasma concentrations of Δ9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharm 21:171s–177s

    Article  Google Scholar 

  • Hollister LE, Richards R K, Gillespie H K (1968) Comparison of Δ9-tetrahydrocannabinol and synhexyl in man. Clin Pharmacol Ther 9:783–791

    Google Scholar 

  • Honecker H C, Coper C (1970) Dünnschichtchromatographische Nachweismethode von Opium als Beimengung in Haschisch-Proben. Dtsch Med Wochenschr 42:441–443

    Google Scholar 

  • Horowitz M J (1969) Flashbacks: recurrent intrusive images after the use of LSD. Am J Psych 126:147–151

    Google Scholar 

  • Hunt C A, Jones RT (1980) Tolerance and disposition of tetrahydrocannabinol in man. J Pharm Exp Ther 215:35–44

    Google Scholar 

  • Huxley A (1972) The doors of perception, (dtsch Übers: Die Pforten der Wahrnehmung. Piper, München)

    Google Scholar 

  • Isbell H, Gorodetzky C W, Jasinsky D, Claussen U, Spulak F, Korte F (1967) Effects of (-)-delta-9-transtetrahydrocannabinol in man. Psychopharmacologia (Berlin) 11:184–188

    Article  Google Scholar 

  • Jacobson C B, Berlin C M (1972) Possible reproductive detriment in LSD users. JAMA 222:1367–1373

    Article  Google Scholar 

  • Jakubovic A, McGeer D (1972) Inhibition of rat brain protein by cannabinoids in vitro. Can J Biochem 50:654–660

    Article  Google Scholar 

  • Janowsky D S, Meacham M P, Blaine J D, Schoor M, Bozetti L P (1976) Simulated flying performance after marihuana intoxication. Aviat Space Environ Med 47:124 128

    Google Scholar 

  • Johnsons, Domino E F (1971) Some cardiovascular effects of marihuana smoking in normal volunteers. Therapeutics 12:762–768

    Google Scholar 

  • Jones H, Jones H C (1977) Sensual drugs. Cambridge Univ Press, Cambridge

    Google Scholar 

  • Jones H C, Lovinger P W (1985) The marijuana question. Mead, New York

    Google Scholar 

  • Jones R (1977) Human effects. NIDA Res Monogr 14:128–178

    Google Scholar 

  • Joyce C R B, Currv S H (1970) The botany and chemistry of cannabis. Churchill, London

    Google Scholar 

  • Kanter S L, Hollister LE (1977) Marihuana metabolites in urine of man. Res Comm Chem Path Pharm 17:421–431

    Google Scholar 

  • Kaiser C, Gold R (1974) Perception, psychedelics and social change. J Psychedelic Drugs 6:30–35

    Article  Google Scholar 

  • Kaplan H S (1971) Psychosis associates with marijuana. NY State J Med 71:433–435

    Google Scholar 

  • Karler R (1977) Toxicological and pharmacological effects. NIDA Res Monogr 14:55–66

    Google Scholar 

  • Karler R, Cely W,Turkanis S A (1974 a) Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids. Life Sci 15:931–947

    Article  Google Scholar 

  • Karler R, Cely W,Turkanis S A (1974 b) A study of the development of tolerance to an anticonvulsant effect of delta-9-THC and cannabidiol. Res Commun Chem Pathol Pharmacol 9:23–29

    Google Scholar 

  • Kaymakcalan S (1975) Potential dangers of cannabis. Int J Addict 10:721–735

    Google Scholar 

  • Keller K, Stahl E (1982) Kalmus: Inhaltsstoffe und Asarongehalt bei verschiedenen Her-künften. Dtsch Apoth Z 122/48:2463–2466

    Google Scholar 

  • Kemali M, Kemali D (1980) Lysergic acid diethylamide: Morphological study of its effects on synapsis. Psychopharmacology 69:315–317

    Article  Google Scholar 

  • Kennedy A B, Ratsch C (1985) Datura: Aphrodisiac? High Frontiers, Berkeley

    Google Scholar 

  • Keup W (1967) Psychotic symptoms due to cannabis abuse (a survey of newly admitted mental patients). Dis Nerv Syst 31:119–126

    Google Scholar 

  • Kielholz P, Hobi V, Ladewig D, Miest P, Richter R (1973) An experimental investigation about the effect of cannabis on car absorption. Pharmakopsychiatry 6:91–103

    Article  Google Scholar 

  • Kleiner D (1992) Eine psychotische Episode mit Verkehrsunfall nach Cannabis-Konsum. Sucht 5:345–346

    Google Scholar 

  • Kleiner D, Stosberg K, Täschner K-L (1993) Erfahrungen mit Cannabiskonsumenten — Ergebnisse einer Umfrage bei Kliniken und Drogenberatungsstellen. Sucht 1:33–45

    Google Scholar 

  • Klonoff H (1983) Acute psychological effects of marihuana in man, including acute cognitive psychomotor and perceptual effects on driving. In: Fehr O’Brien K, Kalant H (eds) Cannabis and health hazards. Addiction Research Foundation, Toronto, pp 88–96

    Google Scholar 

  • Klonoff H, Low M D (1974) Psychological and neurophysiological effects of marihuana in man: An interaction model. In: Miller LL (ed) Marihuana: Effects on human behavior. Academic Press, New York, pp 359–397

    Google Scholar 

  • Knecht S (1962) Magische Pilze. Über die mexikanische Pilzzeremonie. Med Welt 35:1853–1859

    Google Scholar 

  • Kniesel M (1994) Nach der Entscheidung des BVerfG zur Strafbarkeit weicher Drogen. Anfang vom Ende der Drogenpolitik durch Strafrecht. ZRP 9:352–358

    Google Scholar 

  • Koch CAL (1864) Der Hanf. Allg Z Psychiatr 21:13–19

    Google Scholar 

  • Kolansky H, Moore WT (1971) Effects of marihuana on adolescents and young adults. JAMA 216:486–492

    Article  Google Scholar 

  • Konzett H (1981) Halluzinogene: LSD, Psilocybin und Mescalin. Dtsch Ärztebl 78:283–288

    Google Scholar 

  • Korte F et al. (1965) THC-Carbonsäure, ein neuer Haschisch-Inhaltsstoff. Angew Chem 77

    Google Scholar 

  • Kovar K-A (1989) Designer-Drugs — Synthetische Suchtstoffe der 2. Generation, in: Kath. Sozialethische Arbeitsstelle (Hrsg) Designer Drogen. Zum Gefährdungs- und Suchtpotential synthetischer Drogen. Hoheneck, Hamm

    Google Scholar 

  • Kovar K-A, Rösch C, Rupp A (1990) Synthetische Suchtstoffe der 2. Generation. Pharmazie in unserer Zeit Nr. 3

    Google Scholar 

  • Krumsick L (1975) Haschischöl. Kriminalistik 3:124–128

    Google Scholar 

  • Kuehne M E (1964) The total synthesis of vincamine. J Am Chem Soc 86:2946–2973

    Article  Google Scholar 

  • Kuehnle J, Mendelson J H, Davis D R, New P F J (1977) Computer tomographic examination of heavy marihuana smokers. JAMA 237/12:1231–1232

    Article  Google Scholar 

  • Kumar S, Kunwar K B (1972) Chromosome abnormalities in cannabis addicts. J Assoc Phys India 19:193–195

    Google Scholar 

  • Kutney J P, Brown R T, Piers E (1966) The absolute configuration of the Iboga alkaloids. Can J Chem 44:637–645

    Article  Google Scholar 

  • Kvalseth T O (1977) Effects of marijuana on human reaction time and motor control. Percept Mot Skills 45:935–939

    Article  Google Scholar 

  • LaBarre W (1960) Twenty years of peyote studies. Curr Anthropol 1:45–60

    Article  Google Scholar 

  • LaBarre W (1972) Hallucinogens and the shamanic origins of religion. In: Furst PT (ed) Flesh of the Gods: The ritual usees of hallucinogens. Praeger, New York, pp 36–49

    Google Scholar 

  • La Valle S (1984) Hashish. Quarter Books, London New York Melbourne

    Google Scholar 

  • Leaf R C, De Bold R C (1967) LSD, man and society. Wesleyan Univ Press, Connecticut

    Google Scholar 

  • Leary T(1962) How to change behaviour. (Proceedings of XIV. International Congress on Applied Psychology, Copenhagen)

    Google Scholar 

  • Leary T (1964) The religious experience. Psychedelic Rev 3:30–42

    Google Scholar 

  • Leary T (1970) Politik der Ekstase. Wegner, Hamburg

    Google Scholar 

  • Leistenfels H von (oJ) Pilze: Speisepilz-Zucht Rauschpilz-Erkennung. Pieper & Die Grüne Kraft, Löhrbach (Grüner Zweig, Bd 65)

    Google Scholar 

  • Lemberger L, Rubin A (1975) The physiologic disposition of marihuana in man. Life Sci 17:1637–1642

    Article  Google Scholar 

  • Leonhardt R W (1970) Haschischreport. Piper, München

    Google Scholar 

  • Leuenburger H (1969) Zauberdrogen. Goverts, Stuttgart

    Google Scholar 

  • Leuner H (1971) Halluzinogene in der Psychotherapie. Pharmakopsychiatry 4:333–351

    Article  Google Scholar 

  • Leuner H (1981) Halluzinogene. Huber, Bern

    Google Scholar 

  • Levy J A, Munson AE, Harris LS, Dewey WL (1975) Effects of delta-9-THC on the immune response of mice. Fed Proc 34:782–789

    Google Scholar 

  • Lewin L (1927, 1981) Phantastica — Die betäubenden und erregenden Genußmittel. Volksverlag, Linden

    Google Scholar 

  • Lewin L (1929) Banisteria Caapi. Stilke, Berlin

    Google Scholar 

  • Lewis E G, Peters B A, Dustman R E, Straight R C, Beck E C (1976) Sensory, perceptual, motor and cognitive functioning and subjective reports following oral administration of delta-9-THC. Psychopharmacologia (Berlin) 47:141–148

    Article  Google Scholar 

  • Lidz T, Rothenberg A (1970) Psychedelismus: Die Wiedergeburt des Dionysos. Psyche 24:359–374

    Google Scholar 

  • Lockwood T E (1979) The ethnobotany of brugmansia. J Ethnopharmacol 1:147–164

    Article  Google Scholar 

  • Ludlow F H (1981) Der Haschisch-Esser. Sphinx, Basel

    Google Scholar 

  • Madsen W (1955) Shamanism in Mexico. Southwest J Anthropol 2/1:48–57

    Google Scholar 

  • Manno J E, Kiplinger G F, Haine S E, Bennett I F, Forney R B (1970) Comparative effects of smoking marihuana or placebo on human motor and mental performance. Clin Pharmacol Ther 11:808–815

    Google Scholar 

  • Margolis J S, Clorfene R (1979) Der Grassgarten. Volksverlag. Linden

    Google Scholar 

  • Marijuana and Health (1980) 8th Annual Report to the US Congress from the Secretary of Health, Education and Welfare, Washington/DC

    Google Scholar 

  • Marijuana and Health (1985) Report of a study be the committee of the Institute of Medicine. National Acidemic Press, Washington/DC

    Google Scholar 

  • Marzell H (1964) Zauberpflanzen — Hexengetränke. Kosmos 241:47–55

    Google Scholar 

  • Mason A P, McBay A J (1984) Ethanol, marijuana, and other drugs use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978–1981. J Forensic Sci 29:987–1026

    Google Scholar 

  • Mason AP, McBay A J (1985) Cannabis. Pharmacology and Interpretation of effects. J Forensic Sci 30:615–631

    Google Scholar 

  • McBay A J (1985) Marijuana testing and litigation. J Forensic Sci 30:987–994

    Google Scholar 

  • McBay A J (1988) Interpretation of Blood and Urine Cannabinoid Concentrations. J Forens Sci 33:875–883

    Google Scholar 

  • McCann U B, Ridenour A, Shaham Y, Ricaurte G (1994) Serotonin Neurotoxicity after MDMA (,Ecstasy ‘): A controlled Study in Humans. Am Coll of Neuropsychopharma-cology 2:129–138

    Google Scholar 

  • McCullum N K, Shaw SM (1981) Chromatographic analysis for Δ9-tetrahydrocannabinol in blood and brain. J Anal Tox 5:148–149

    Article  Google Scholar 

  • McDonald P A, Martin CF, Woods DJ, Baker PB, Gough TA (1984) An analytical study of illicit lysergide. J Forens Sci 29:120–130

    Google Scholar 

  • McGlothlin W S, Cohen S, McGlothlin M (1964) Short-term effects of LSD on anxiety, attitudes and performance. J Nerv Ment Dis 139:266–273

    Article  Google Scholar 

  • McGlothlin W S, Cohen S, McGlothlin M (1970) Long lasting effects of LSD on normals. J Psychedelic Drugs 3:20–31

    Article  Google Scholar 

  • McLeary J A, Sypherd P S, Walkington D L (1960) Antibiotic activity of an extract of peyo-te Lophophora williamsii (Lemaire) Coulter. Econ Bot 14:247–249

    Article  Google Scholar 

  • Mechoulam R (1970) Marihuana chemistry. Science 168:1159–1166

    Article  Google Scholar 

  • Mechoulam R (1973) Marihuana-Chemistry, pharmacology, metabolism and clinical effects. Academic Press, London

    Google Scholar 

  • Mechoulam R, Gaoni Y (1965) A total synthesis of d,l-delta-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273–3275

    Article  Google Scholar 

  • Mechoulam R et al. (1994) Search for endogenous ligands of the cannabinoid receptor. Bio-chem Pharmacol 48:1537–1540

    Article  Google Scholar 

  • Meek B (1981) Die Assassinen. Econ, Düsseldorf Wien

    Google Scholar 

  • Melges FT, Tinklenberg J R, Hollister LE, Gillespie H K (1970) Marihuana and temporal disintegration. Science 6:1118–1120

    Article  Google Scholar 

  • Mendelson J H (ed) (1974) The use of marihuana. Plenum, New York

    Google Scholar 

  • Mendelson JH (1987) Marijuana. In: Meltzer H Y (ed) Psychopharmacology, Raven, New York, pp 60–67

    Google Scholar 

  • Mendelson J H, Rossi A M, Meyer R E (eds) (1974) The use of marihuana; a psychological and physiological inquiry. Plenum, New York

    Google Scholar 

  • Merkus F et al. (1971) TLC, GLC and MS of cannabidivarin, tetrahydrocannabivarin and cannabivarin. Acta Pharm Suec 8

    Google Scholar 

  • Miller LL (ed) (1974) Marijuana — effects on human behavior. Academic Press, New York San Fransisco London

    Google Scholar 

  • Miller R A (1983) The magical and ritual use of herbs. Destiny, New York

    Google Scholar 

  • Morton J F (1981) Atlas of medical plants of middel america. Thomas, Springfield/IL

    Google Scholar 

  • Moskowitz H, McGlothlin WS (1974) Effects of marihuana on auditory signal detection. Psychopharmacologia (Berlin) 48:159–163

    Google Scholar 

  • Munzinger M (1978) Vergiftungen durch Rauschmittel, Opiate, Halluzinogene, Weckamine. Notfallmed 4:650–657

    Google Scholar 

  • Murray J B (1985) Marihuana’s Effects on Human Cognitive Functions, Psychomotor Functions, and Personality. J Gen Psychol 113:23–55

    Article  Google Scholar 

  • Myerhoff B G (1980) Der Peyote Kult. Trikont, München

    Google Scholar 

  • Nahas G G (1972) Toxicology and pharmacology of cannabis sativa with special reference to delta-9-THC. Bull Narc 24:11–27

    Google Scholar 

  • Nahas G G (1974) Effects of cannabis and cannabinoids on cell replication and replication and DNA synthesis in man. J Pharmacol 5:71 78

    Google Scholar 

  • Nahas G G (1975) Marihuana — Deceptive Weed. Raven Press, New York

    Google Scholar 

  • Nahas G G (1979) Keep off the grass. Pergamon, Oxford New York

    Google Scholar 

  • Nahas G G (1982) Hashish in Islam, 9th to 18th century. Bull NY Acad Med 58/9:814–831

    Google Scholar 

  • Nahas G G (ed) (1984) Marihuana in science and medicine. Raven, New York

    Google Scholar 

  • Nahas G G (1986) Cannabis: toxicological properties and epidemiological aspects. Med J Aust 145:82–87

    Google Scholar 

  • Nahas G G, Patton W D M (eds) (1979) Marihuana. Biological effects analysis, metabolism, cellular responses, reproduction and brain. Pergamon, Oxford

    Google Scholar 

  • Nahas G G, Sucia-Foca N, Armand J-P. Morishima S (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183:419–420

    Google Scholar 

  • Nahas G G, Desoize B, Hsu J, Morishima A, Srinivasan PR (1975) Inhibition of nucleic acid and proteins synthesis by natural cannabinoids and olivetol. (Abstract, IV. Int. Congress of Pharmacology, Helsinki, p 495)

    Google Scholar 

  • Nahas G G, Paton W D M, Idänpään Heikkilä J E (eds) (1976) Marihuana: chemistry, biochemistry and cellular effects. Springer, New York

    Google Scholar 

  • Nahas G G, Latour Z (1992) The human toxicity of marijuana, MedJAnst 156(7):495–497

    Google Scholar 

  • Negrete J C (1973) Psychological adverse effects of cannabis smoking. A tentative classification. Can Med Assoc J 108:195–196

    Google Scholar 

  • Neu R L, Powes H O, King S, Gardner L I (1969) Cannabis and chromosomes. Lancet 1:675

    Article  Google Scholar 

  • Neumeyer JL, Shagoury L (1971) Chemistry and pharmacology of marijuana. J Pharm Sci 60:1433–1451

    Article  Google Scholar 

  • Neuninger H (1988) Zur Bewertung von inländischen Cannabis-Produkten. Österr RichterZ 66:127–130

    Google Scholar 

  • Nichols W W, Miller R C, Heneen W, Bradt C, Hollister L, Kanter S (1974) Cytogenetic studies on human subjects receiving marihuana and delta-9-tetrahydrocannabinol. Mutat Res 26:413–417

    Article  Google Scholar 

  • Novotny M, Lee M C, Keast D (1976) A possible chemical basis for the higher mutagenicity of marihuana smoke as compared to tobacco smoke. Experientia 32:280–282

    Article  Google Scholar 

  • Nowlan R, Cohen S (1977) Tolerance to marihuana: heart rate and subjective „high“. Clin Pharmacol Ther 22:550–555

    Google Scholar 

  • Ohlsson A, Lindgren J E, Wahlen A et al. (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinic effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409–116

    Article  Google Scholar 

  • Olvedi U (1972) LSD-Report. Suhrkamp, Frankfurt am Main

    Google Scholar 

  • Orzechowski G (1969) Halluzinogene Drogen. Med Welt 16:955–963

    Google Scholar 

  • Oss O T, Oeric O N (1976) Psilocybin, magic mushrooms grower’s guide. And/Or Press, Berkeley

    Google Scholar 

  • Ott J (1976) Hallucinogenic plants of North America. Wingbow, Berkeley/CA

    Google Scholar 

  • Ott J, Bigwood J (ed) (1978) Teonanacatl: Hallucinogenic mushrooms of North America. Madrona, Seattle/WA

    Google Scholar 

  • Pace H D, Davis A, Borgen L A (1971) Teratogenesia and marihuana. Ann NY Acid Sci 191:123–128

    Article  Google Scholar 

  • Pahnke W(1963) Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness. Master’s thesis Univ of Harvard

    Google Scholar 

  • Payne R J, Brand S N (1975) The toxicity of intravenously used marihuana. J Am Med Assoc 233:351–354

    Article  Google Scholar 

  • Peel H W, Perrigo B J (1981) Detection of cannabinoids in blood using EMIT. J Anal Tox 5:165–167

    Article  Google Scholar 

  • Perez-Reyes M, Owens S M, DiGuiseppe S (1981) The clinical pharmacology and dynamics of marihuana cigarette smoking. J Clin Pharm 21:201S-207S

    Article  Google Scholar 

  • Peronka S, Newman M, Harris H (1988) Subjective Effects of DOM in Recreational Users. Neuropsychopharmacology 1:273–277

    Google Scholar 

  • Petersen B H, Graham J, Lemberger L (1976) Marihuana, tetrahydrocannabinol and T-cell function. Life Sci 19:395–400

    Article  Google Scholar 

  • Petersen RC (ed) (1977) Marihuana research findings. NIDA Res Monogr 14:205–218

    Google Scholar 

  • Petersen R C (ed) (1980) Marijuana research findings. NIDA Res Monogr 31:69–85

    Google Scholar 

  • Petersen R C, Stillman R C(1978) Phencyclidine (PCP) abuse: An appraisal. NIDA Res Monogr 21:168–175

    Google Scholar 

  • Petrzilka T, Haefliger W, Sikemeier G, Ohloff G, Eschenmoser A (1967) Synthese und Chi-ralität des (-)-Cannabidiols. Helv Chim Acta 50:719–723

    Article  Google Scholar 

  • Peuckert W-E (1960) Hexensalben. Med Monatsspiegel 9:169–174

    Google Scholar 

  • Pope H G Jr (1969) Tabernanthe iboga — an African narcotic plant of social importance. Econ Bot 23:174–184

    Article  Google Scholar 

  • Raffauf R F, Flagler M B (1960) Alkaloids of the apocynaceae. Econ Bot 14:37–46

    Article  Google Scholar 

  • Randall T (1992) „Rave“ Scene, Ecstasy Use, Leap Atlantic. JAMA 268:1506

    Article  Google Scholar 

  • Ranke-Graves R von (1985) Griechische Mythologie. Rowohlt, Reinbek

    Google Scholar 

  • Ray R, Prabhu GG, Mohan D, Nath LM, Neki JS (1978) Cannabis use. The association between chronic cannabis abuse and cognitive functions. Drug Alcohol Dep 3:365–368

    Article  Google Scholar 

  • Rayner R (1979) Pilze erkennen — leicht gemacht. Franck’sche Verlagshandlung, Stuttgart

    Google Scholar 

  • Reed A, Kane W (1972) Phencyclidine (PCP). J Psychedelic Drugs 5/1:8–12

    Article  Google Scholar 

  • Reeve V C, Grant J D,Robertson W et al. (1983 a) Plasma concentration of delta-9-tetrahy-drocannabinol and impaired motor function. Drug Alcohol Dep 11:167–175

    Article  Google Scholar 

  • Reeve V C, Robertson W B, Grant J et al. (1983b) Hemolyzed blood and serum levels of Δ9-THC: Effects on the performance of roadside sobriety tests. J Forensic Sci 28:963–971

    Google Scholar 

  • Remschmidt H (1972) Haschisch und LSD. Physische und psychische Wirkungen. Med Klin 67:706–716,781–786

    Google Scholar 

  • Renault PF, Schuster CR, Heinrich R, Freeman DX (1971) Marihuana: Standartized smoke administration and dose effects surves on heart rate in humans. Science 174:589–591

    Article  Google Scholar 

  • Ricklin F (1989) Cannabis: harmloses Rauschgift? Schweiz Med Wochenschr 119:1173–1176

    Google Scholar 

  • Rivier L, Lindgren J-E (1972) Ayahuasca- South American hallucinogenic drink: ethnobo-tanical and chemical investigations. Econ Bot 24:100–129

    Google Scholar 

  • Rodin E, Domino E, Porzak J (1970) The marijuana induced social high — Neurological and electroencephalographic concomitants. JAMA 213:1300–1302

    Article  Google Scholar 

  • Rosenthal E (1984) Marijuana beer. And/Or Press, Berkeley

    Google Scholar 

  • Safford W E (1916) Identity of cohoba, the narcotic snuff of ancient Haiti. J Wash Acad Sci 6:548–562

    Google Scholar 

  • Sahihi A (1989) Designer-Drogen: die neue Gefahr. Beltz, Weinheim Basel

    Google Scholar 

  • Sallan S E, Zinberg N E, Frei E (1975) Antimetic effect of delta-9-THC in patients receiving cancer chemotherapy. N Eng J Med 293:795–797

    Article  Google Scholar 

  • Sankar D V S (1975) LSD — A total study. PJD Publications, Westbury/NY

    Google Scholar 

  • Sankar D V S, Roszy P W, Geisler A (1969) Chromosome breakage in childern treated with LSD-25 and UML-491. Compr Psychiatry 10:406–410

    Article  Google Scholar 

  • Saunders N (1994) „Ecstasy“. Bilger, Zürich

    Google Scholar 

  • Saxton JE (1956) The indole alkaloids excluding harmine and strychnine. Q Rev 10:108–112

    Article  Google Scholar 

  • Schleifer H (1973) Sacred narcotic plants of the New World Indians. Hafner, New York

    Google Scholar 

  • Schmidt P, Scheer N, Berghaus G (1995) Cannabiskonsum und Fahrtüchtigkeit. Kriminalistik 4:241–246

    Google Scholar 

  • Schmiechen R et al. (1986) Carbolines — A new class of compounds with high affinity for benzodiazepine receptors. (Sonderdruck: IXth Int. Symposium on Medicinal Chemistry, Berlin)

    Google Scholar 

  • Schönhofer P S (1973) Die Pharmakologie der Cannabis-Wirkstoffe. Arzneimittelforsch 23:50–55

    Google Scholar 

  • Schreiber LH (1995) Cannabisforschung — Der aktuelle Stand der Dinge. Kriminalistik 12:803–806

    Google Scholar 

  • Schultes R E (1941) A contribution to our knowledge of rivea corymbosa, the narcotic olo-liuqui of the Aztecs. Harvard Botanical Museum, Cambridge/MA

    Google Scholar 

  • Schultes R E (1969) Hallucinogens of plant origin. Science 163:245–254

    Article  Google Scholar 

  • Schultes R E (1969/1970) The plant kingdom and hallucinogens. Bull Narc 21:3–16, 22:25–53

    Google Scholar 

  • Schultes RE (1970a) The botanical and chemical distribution of hallucinogens. Ann Rev Plant Physiol 21:571–590

    Article  Google Scholar 

  • Schultes R E (1970 b) Botany and chemistry of cannabis. Churchill, London

    Google Scholar 

  • Schultes R E (1972) An overview of hallucinogens in the western hemisphere. In: Fürst PT (ed) Flesh of the Gods: The ritual uses of hallucinogens. Praeger, New York, pp 3–54

    Google Scholar 

  • Schultes RE (1976) Hallucinogenic plants. Golden Press, New York

    Google Scholar 

  • Schultes R E, Hofmann A (1980 a) The botany and chemistry of hallucinogens. Thomas, Springfield/IL

    Google Scholar 

  • Schultes RE, Hofman A (1980b) Pflanzen der Götter. Die magischen Kräfte der Rauschund Giftgewächse. Hallwag, Bern Stuttgart

    Google Scholar 

  • Schultz O E, Haffner C (1958) Zur Kenntnis eines sedativen Wirkstoffes aus dem deutschen Faserhanf. Arch Pharm (Berlin) 291:20–24

    Article  Google Scholar 

  • Schulz V (1984) Behandlung des Ergotismus, Fortschr Med 8:189–190

    Google Scholar 

  • Schurz J (1970) Vom Bilsenkraut zum LSD. Frank’sche Verlagshandlung, Stuttgart

    Google Scholar 

  • Schwarz CJ (1968) The complications of LSD: a review of the literature. J Nerv Ment Dis 146:174–186

    Article  Google Scholar 

  • Sharma S, Moskowitz H (1972) Effect of marihuana on the visual autokinetic phenomenon. Percept Mot Skills 35:891–894

    Article  Google Scholar 

  • Silverman J (1968) Shamans and acute schizophrenia. Am Anthropol 69:21–31

    Article  Google Scholar 

  • Smith M V (1981) Psychedelic chemistry. Loompanics Unlimited Mason/USA (Nachdruck des 1973 in Rip Off Press erschienenen Werkes)

    Google Scholar 

  • Smith P B et al. (1994) The Parmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice. J of Pharmacol 270:219–220

    Google Scholar 

  • Smith RN, Robinson K (1985) Body fluid levels of lysergide (LSD). Forensic Sci Int 28:229–237

    Article  Google Scholar 

  • Soueif MI (1976) Differential association between chronic cannabis use and brain function deficits. Ann NY Acad Sci 282:323–343

    Article  Google Scholar 

  • de Souza E, Battaglia G, Insel T(1990) Neurotoxic Effects of MDMA on Brain Serotonin Neurons: Evidence from Neurochemical and Radioligand Binding Studies. Ann NY Acad Sci 6:682–698

    Article  Google Scholar 

  • Stafford P (1980) Enzyklopädie der psychedelischen Drogen. Volksverlag, Linden

    Google Scholar 

  • Stahl E et al. (1978) Rauschgiftpilze mit LSD. Arch Krim, S 162

    Google Scholar 

  • Stanton M D, Mintz J, Franklin RM (1976) Drug flashbacks. II. Some additional findings. Int J Addict 11:53–69

    Google Scholar 

  • Starks M (1979) Marijuana potency. And/Or Press, Berkeley

    Google Scholar 

  • Steckel R (oJ) Bewußtseinserweiternde Drogen. Haschisch — Marihuana — LSD — Meskalin — STP (DOM) — Psilocybin — Ololiuqui. Edition Voltaire

    Google Scholar 

  • Stefanis C, Dornbush R, Fink M (1977) Hashish-studies of long-term use. Raven, New York

    Google Scholar 

  • Stenchever M A, Kunysz T J, Allen M A (1974) Chromosome breakage in users of marihuana. Am J Obstet Gynecol 118:106–113

    Google Scholar 

  • Stoll W A (1947) Lysergsäureamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz Arch Neurol Psychiatr 60:279 323

    Google Scholar 

  • Stoll WA (1952) Recent investigations on ergot alkaloids. Fortschr Chem Org Naturst 9:114–119

    Google Scholar 

  • Stosberg K, Lösch H (1987) Haschisch-Spätfolgen, Suchtreport 5:13–16

    Google Scholar 

  • Stowe B B (1959) Occurence and metabolism of simple indoles in plants. Fortschr Chem Org Naturst 17:248–252

    Google Scholar 

  • Stringaris M G (1972) Die Haschischsucht. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Stromberg V L (1954) The isolation of bufotenin from Piptadenia peregrina. J Am Chem Soc 76:170–171

    Article  Google Scholar 

  • Sullivan A T, Twitchett P J, Fletcher S M, Moffat AC (1978) The fate of LSD in the body: forensic considerations. J Forens Sci 18:89–98

    Article  Google Scholar 

  • Svrcek M (1979) Der Kosmos-Pilzführer. Franck’sche Verlagshandlung, Stuttgart

    Google Scholar 

  • Swatek R (1984) Marijuana use: Persistence and urinary elimination. J Substance Abuse Treatment 1:265–270

    Article  Google Scholar 

  • Täschner K-L (1980) Haschisch für alle. Hess Ärztebl 7 (Sonderdruck)

    Google Scholar 

  • Täschner K-L (1981) Das Haschischproblem aus klinischer Sicht. Dtsch Ärztebl 78:126–129

    Google Scholar 

  • Täschner K-L (1983) Zur Psychopathologie und Differentialdiagnose sogenannter Canna-bispsychosen. Fortschr Neurol Psychiatr 51:235–248

    Article  Google Scholar 

  • Täschner K-L (1986) Das Cannabisproblem — Haschisch und seine Wirkungen. Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  • Täschner K-L, Frießem D H (1989) Verkehrstauglichkeit bei Rauschgiftkonsumenten unter besonderer Berücksichtigung des Cannabismißbrauchs. Suchtgefahren 35:253–262 (Sonderdruck)

    Google Scholar 

  • Täschner K-L, Wanke K(1975) Zur Frage der toxischen Psychose am Beispiel der sog. LSD-Psychose. Fortschr Med 31:1515–1518, 1542

    Google Scholar 

  • Tarshis M S (1972) The LSD controversy — an overview. Thomas, Springfield/IL

    Google Scholar 

  • Tashkin D P (1987) Marjhuana-Bronchitis. Am Rev Resp Dis 135:209

    Google Scholar 

  • Tashkin D P, Simmons M, Clark V (1988) Effect of habitual smoking of marijuana alone and with tobacco on nonspecific airways hyperreactivity. J Psychoactive Drugs 20:21–25

    Article  Google Scholar 

  • Taylor F M (1988) Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J 81:1213–1216

    Article  Google Scholar 

  • Taylor W I (1966) Indole alkaloids, an introduction to the enamine chemistry of natural products. Pergamon, New York

    Google Scholar 

  • Teale J D, Forman E J, King L J (1975) The development of a radioimmunassay for cannabi-noids in blood and urine. J Pharm Pharmac 27:465–472

    Article  Google Scholar 

  • Tennant F S, Groesbeck C J (1972) Psychiatric effects of Hashish. Arch Gen Psychiatry 27:133–136

    Article  Google Scholar 

  • Tennant F S, Preble M, Prendergast T J, Ventry P (1971) Medical manifestations associated with Hashish. JAMA 216:1965–1969

    Article  Google Scholar 

  • Thomas WR, Holt P G, Keast D (1974) Recovery of immune system after cigarette smoking. Nature 248:358–359

    Article  Google Scholar 

  • Treffert D A (1978) Marihuana use in schizophrenia: a clear hazard. Am J Psychiatry 135:1213–1215

    Google Scholar 

  • Ungerleider J T et al. (1968) The „bad trip“ — the etiology of the adverse LSD reaction. Am J Psvchiatry 124:1483–1490

    Google Scholar 

  • Vierth G (1967) Psycho-pathologische Syndrome nach Haschischgenuß. MMW 1:522 528

    Google Scholar 

  • Vogel R, Matthiessen W, Bruckner O, Alexander M (1981) Lungenkomplikationen bei Rauschgiftsucht. Prax Pneumol 35:988–991

    Google Scholar 

  • Völger G (Hrsg) (1982) Rausch und Realität, Drogen im Kulturvergleich, Bde 1–3. Rowohlt, Reinbek (Materialienband zur Ausstellung des Rautenstrauch-Joest-Museums für Völkerkunde der Stadt Köln 1981, Teil 1 und 2)

    Google Scholar 

  • Waser P (1971) pharmakologische Wirkungsspektren von Halluzinogenen. Bull Schweiz Akad Med Wiss 27:39–57

    Google Scholar 

  • Wasson R G (1959) The hallucinogenic mushrooms of Mexiko. Academy of Science, New York

    Google Scholar 

  • Wasson R G (1962) The hallucinogenic mushrooms of Mexiko and psilocybin: a bibliography. Bot Mus Leafl Harv Univ 20:20–73

    Google Scholar 

  • Wasson R G (1968) Soma. Divine mushroom of immortality. Harcourt Brace Jovanovich, New York

    Google Scholar 

  • Wasson V P, Wasson R G (1957) Mushrooms. Russia and history. Pantheon, New York

    Google Scholar 

  • Wasson R G, Hofman A, Ruck C A P (1978) The road to Eleusis: Unveiling the secrets of the mysteries. Harcourt Brace Jovanovich, New York

    Google Scholar 

  • Wax RH, Wax ML (1962) The magical world view. J Sci Study Rel 1:179–188

    Article  Google Scholar 

  • Wells B (1974) Psychedelic drugs. Penguin, Baltimore

    Google Scholar 

  • Whites S C, Brin S C, Janicki B W (1975) Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers. Science 188:71–72

    Article  Google Scholar 

  • Williams E G, Himmelsbach C K, Wikler A, Ruble D C, Lloyd B J Jr (1946) Studies on marijuana and parahexyl compound. Public Health Rep 61:1059–1083

    Article  Google Scholar 

  • Winterfeldt E (1971) Neuere Aspekte in der Chemie der Indolalkaloide. Chimia 25:394–396

    Google Scholar 

  • Winterfeldt E (1974) Stereoselektive Totalsynthese von Indolalkaloiden. Fortschr Chem Org Naturst 31:469–472

    Article  Google Scholar 

  • Woggon B (1974) Haschisch — Konsum und Wirkung. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Yago K B, Pitts FN Jr, Burgoyne R W et al. (1981) The urban epidemic of phencyclidine (PCP) use. J Clin Psychiatry 42:193–196

    Google Scholar 

  • Zellweger H, McDonald J S, Abbo G (1967) Is isoergicacid diethylamide a teratogen? Lancet 7525:1066–1068

    Article  Google Scholar 

  • Zimmermann A M, Raj A Y (1980) Influence of cannabinoids on somatic cells in vivo. Pharmacology 21:277–287

    Article  Google Scholar 

  • Zimmerman S, Zimmerman A M, Cameron IL, Laurence H L (1977) Delta-9-tetrahydro-cannabinol, cannabidiol, and cannabinol effects on the immune response of mice. Pharmacology 15:10–23

    Article  Google Scholar 

  • Zschockelt A (1986) Die „nicht geringe Menge“ Cannabis — Problematik der THC-Bestim-mung. MDR 6:457–459

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Katharina-Belgica-Str. 22b, D-63450, Hanau, Deutschland

    Thomas Geschwinde

Authors
  1. Thomas Geschwinde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Geschwinde, T. (1997). Psychodysleptica. In: Rauschdrogen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09679-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-09679-6_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61105-9

  • Online ISBN: 978-3-662-09679-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation